Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Regeneron's Eylea smashes Phase 3 trial goal in diabetic retinopathy

pharmafileMarch 21, 2018

Tag: Regeneron , trial

PharmaSources Customer Service